Suggest Edits

Be The First To
Add Photos

Headquarters Cambridge, MA
Size 150 to 499 Employees
Founded Unknown
Type Company - Public (ALNY)
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year
Competitors Pfizer, Biovail

Call it The Silence of the Genes. Alnylam Pharmaceuticals runs interference with RNA to prevent disease. RNA interference (RNAi) technology developed by the biotech firm can selectively shut off harmful genes. The company is developing a pipeline of candidates both individually and through collaborations with other drugmakers. Its disease targets include rare genetic disorder ATTR (transthyretin-mediated amyloidosis) and RSV (respiratory syncytial virus), a common childhood viral infection. Additional R&D programs target neurological disorders, cardiovascular conditions... More

Working at Alnylam

Posted by employees

Employees are “Satisfied”   7 ratings


85% Approve of the CEO   6 ratings

Alnylam CEO and Director John M. Maraganore

John M. Maraganore

CEO and Director


  Former Intern in Cambridge, MA

Pros: learning opportunities, good culture, smaller company Full Review

More Alnylam Ratings & Reviews ( 7)

Salaries in USD  United States Avg. Salary


10 Alnylam Salaries


Senior Scientist

8 Alnylam Salaries


Senior Research Associate

3 Alnylam Salaries


= Salary Range

= Anonymous Salary Range

= Avg.

More Alnylam Salaries (36)

Accepted Offer – Reviewed Jul 25, 2013

Interview Details – Hiring was fast and aggressive. I only had a weekend to review the offer and submit my answer. The interview did not require a presentation and met with colleagues on 2 different visits. Everyone was nice and the discussions focused on relevant information.Full Interview

Interview Question:
Nothing out of the ordinary Answer Question

More Alnylam Interview Questions & Reviews (2)

Alnylam Awards & Accolades

Something missing? Add an award
Top Places to Work Globe 100, Boston Globe, 2008

Worked for Alnylam? Contribute to the Community!